VK

Venkateswararao Kondreddy

Active Director Designated Partner DIN 02907769
DIN 02907769 First appointment May 2010 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 9 historical roles
Total affiliations 11 Since May 2010
Shareholding value •••• Premium profile

About Venkateswararao Kondreddy

Data last updated:

Venkateswararao Kondreddy has 16 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Epravinya Solutions Llp and Hyacinths Pharma Private Limited. Formerly with 9 companies, such as Apl Research Centre Limited and Auro Peptides Limited. Engaged in General Business, Technology and more. Contributes to corporate operations. The largest current company by reported revenue is Raidurgam Developers Limited at ₹190 Cr (FY 2025).

DIN 02907769
Primary Designation Designated Partner
First Appointment 21 May 2010
Oldest Company Age 18 yrs
Largest company Raidurgam Developers Limited · ₹190 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Raidurgam Developers Limited U45100TG2012PLC081892
Director30 Jun 20172012₹190 Cr (FY 2025)Active
Designated Partner13 Jan 20252025–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apl Research Centre Limited U24116TG2006PLC051171
Director24 Aug 20152006–Amalgamated
Auro Peptides Limited U24232TG2012PLC078350
Director22 Aug 20162012₹23.52 Cr (FY 2025)Active
Apl Healthcare Limited U24239TG2006PLC052053
Director24 Aug 20152006₹4,413 Cr (FY 2025)Active
Eugia Pharma Specialities Limited U24297TG2013PLC087048
Director24 Aug 20152013₹4,829 Cr (FY 2025)Active
Apitoria Pharma Private Limited U24298TG2017PTC121342
Additional Director10 Jun 20192017₹6,812 Cr (FY 2025)Active
Auronext Pharma Private Limited U74999TG2009PTC109591
Director25 Aug 20152009₹75.8 Lakh (FY 2023)Amalgamated
Hyacinths Pharma Private Limited U24232TG2010PTC069638
Director18 Sep 20172010–Amalgamated
Director21 May 20102010–Strike Off
Director28 Feb 20182008₹139 Cr (FY 2020)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Epravinya Solutions Llp
Hyacinths Pharma Private Limited
Raidurgam Developers Limited
Prowinhealth Technologies Private Limited
Premium access

Shareholding and investment profile for Venkateswararao Kondreddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkateswararao Kondreddy

Venkateswararao Kondreddy has 16 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Epravinya Solutions Llp and Hyacinths Pharma Private Limited. Formerly with 9 companies, such as Apl Research Centre Limited and Auro Peptides Limited. Engaged in General Business, Technology and more. Contributes to corporate operations. The largest current company by reported revenue is Raidurgam Developers Limited at ₹190 Cr (FY 2025).

Venkateswararao Kondreddy is associated with 2 companies as Designated Partner and Director, including Raidurgam Developers Limited (₹190 Cr), Epravinya Solutions Llp.

Venkateswararao Kondreddy has expertise in General Business, Technology and other sectors.

Venkateswararao Kondreddy has 16 years in corporate governance.

By reported revenue, the largest current company of Venkateswararao Kondreddy is Raidurgam Developers Limited, with revenue of ₹190 Cr (FY 2025).

Venkateswararao Kondreddy currently holds positions at 2 companies: Raidurgam Developers Limited (₹190 Cr), Epravinya Solutions Llp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available